Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-04-16 Sale |
2025-04-17 4:53 pm |
IONIS PHARMACEUTICALS INC | IONS | Jenne Kyle EVP, Chf GL Pdt Str Ofcr |
3,016 | $28.36 | $85,534 | 47,876 (Direct) |
View |
| 2020-09-22 Sale |
2020-09-24 4:21 pm |
AKCEA THERAPEUTICS INC. | AKCA | Jenne Kyle Chief Commercial Officer |
720 | $18.12 | $13,046 | 52,012 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-15 Exercise |
2025-04-17 4:53 pm |
N/A N/A |
IONIS PHARMACEUTICALS INC | IONS | Jenne Kyle EVP, Chf GL Pdt Str Ofcr |
12,226 | $0 | 47,876 (Direct) |
View |
| 2025-01-15 Option Award |
2025-01-17 7:40 pm |
2028-01-15 N/A |
IONIS PHARMACEUTICALS INC | IONS | Jenne Kyle EVP, Chf GL Pdt Str Ofcr |
46,750 | $0 | 46,750 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 4:55 pm |
2026-01-02 2035-01-01 |
IONIS PHARMACEUTICALS INC | IONS | Jenne Kyle EVP, Chf GL Pdt Str Ofcr |
18,700 | $0 | 18,700 (Direct) |
View |
| 2024-02-26 Option Award |
2024-03-13 5:52 pm |
2025-02-26 2034-02-25 |
IONIS PHARMACEUTICALS INC | IONS | Jenne Kyle EVP, Chf GL Pdt Str Ofcr |
65,203 | $0 | 65,203 (Direct) |
View |
Ownership |
2024-03-13 5:52 pm |
N/A N/A |
IONIS PHARMACEUTICALS INC | IONS | Jenne Kyle EVP, Chf GL Pdt Str Ofcr |
0 | $0 | 1,989 (Direct) |
View |
| 2020-10-12 Equity Swap |
2020-10-13 3:59 pm |
N/A N/A |
AKCEA THERAPEUTICS INC. | AKCA | Jenne Kyle Chief Commercial Officer |
52,012 | $18.15 | 0 (Direct) |
View |